Cynosure Group LLC Has $781,000 Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Cynosure Group LLC decreased its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 21.0% in the third quarter, HoldingsChannel reports. The firm owned 1,955 shares of the biotechnology company’s stock after selling 521 shares during the period. Cynosure Group LLC’s holdings in Axon Enterprise were worth $781,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. PFG Investments LLC raised its holdings in shares of Axon Enterprise by 0.6% during the third quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company’s stock valued at $1,547,000 after acquiring an additional 25 shares during the period. Gladstone Institutional Advisory LLC raised its stake in Axon Enterprise by 1.6% during the 3rd quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company’s stock valued at $656,000 after purchasing an additional 26 shares during the period. Mather Group LLC. lifted its holdings in shares of Axon Enterprise by 3.7% in the third quarter. Mather Group LLC. now owns 759 shares of the biotechnology company’s stock valued at $303,000 after purchasing an additional 27 shares in the last quarter. King Luther Capital Management Corp boosted its position in shares of Axon Enterprise by 0.3% in the third quarter. King Luther Capital Management Corp now owns 10,474 shares of the biotechnology company’s stock worth $4,185,000 after buying an additional 34 shares during the period. Finally, CWM LLC grew its holdings in shares of Axon Enterprise by 1.3% during the third quarter. CWM LLC now owns 2,856 shares of the biotechnology company’s stock valued at $1,141,000 after buying an additional 36 shares in the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling at Axon Enterprise

In other news, President Joshua Isner sold 20,000 shares of the stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the completion of the sale, the president now owns 208,166 shares of the company’s stock, valued at $126,179,820.90. This represents a 8.77 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Jeffrey C. Kunins sold 21,834 shares of the business’s stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the completion of the sale, the insider now directly owns 154,394 shares in the company, valued at $91,691,508.72. This represents a 12.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 260,256 shares of company stock valued at $105,984,120. Company insiders own 5.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on AXON shares. Northland Securities boosted their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. Robert W. Baird boosted their target price on shares of Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. Needham & Company LLC boosted their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. The Goldman Sachs Group lifted their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Finally, Craig Hallum increased their target price on shares of Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research report on Wednesday, August 7th. Two investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat, Axon Enterprise presently has a consensus rating of “Moderate Buy” and an average target price of $427.83.

Axon Enterprise Price Performance

Axon Enterprise stock opened at $632.16 on Wednesday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 1 year low of $224.28 and a 1 year high of $641.20. The business has a 50-day moving average of $468.24 and a 200-day moving average of $370.65. The firm has a market capitalization of $48.20 billion, a P/E ratio of 163.35, a PEG ratio of 13.62 and a beta of 0.94.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.